Abstract
Protein kinase A (PKA) plays a pivotal role in various biological processes and the pathogenesis of several diseases. However, systematic investigation of PKA functions in cells and tissues is limited due to the lack of a suitable high-throughput in situ PKA activity assay. Here, we present an array-based in situ PKA activity assay that employs selective detection of the catalytic form of PKA (cPKA; active and autophosphorylated) using antibody arrays. Antibody arrays were fabricated by applying anti-cPKA antibody onto welltype amine arrays. The limit of detection was 0.02 μg/ mL. We successfully applied this assay to determine changes in intracellular and extracellular PKA activities in human gastric adenocarcinoma (AGS) cells and human umbilical vein endothelial cells (HUVECs) treated with forskolin. Forskolin induced activation of intracellular PKA in a dose-dependent manner, and this PKA activation was inhibited by the potent PKA inhibitor H-89. Extracellular PKA activity was also elevated by forskolin in a dose-dependent manner in AGS cells, but this elevation was hardly detectable in HUVECs. Thus, our antibody array-based in situ PKA activity assay is suitable for investigating the regulation and functions of intracellular and extracellular PKA in cells and tissues and has a potential for use in cancer diagnosis.
Similar content being viewed by others
References
Kong, D.H. et al. A peptide array-based serological protein kinase A activity assay and its application in cancer diagnosis. Analyst 140, 6588–6594 (2015).
Skalhegg, B.S. & Tasken, K. Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Front. Biosci. 5, D678–693 (2000).
Cheung, J. et al. Structural insights into mis-regulation of protein kinase A in human tumors. Proc. Natl. Acad. Sci. USA 112, 1374–1379 (2015).
Sands, W.A. & Palmer, T.M. Regulating gene transcription in response to cyclic AMP elevation. Cell. Signal. 20, 460–466 (2008).
Lefkimmiatis, K. & Zaccolo, M. cAMP signaling in subcellular compartments. Pharmacol. Ther. 143, 295–304 (2014).
Gold, M.G., Gonen, T. & Scott, J.D. Local cAMP signaling in disease at a glance. J. Cell Sci. 126, 4537–4543 (2013).
Czyzyk, T.A., Sikorski, M.A., Yang, L. & McKnight, G.S. Disruption of the RIIbeta subunit of PKA reverses the obesity syndrome of Agouti lethal yellow mice. Proc. Natl. Acad. Sci. USA 105, 276–281 (2008).
Gerthoffer, W.T., Solway, J. & Camoretti-Mercado, B. Emerging targets for novel therapy of asthma. Curr. Opin. Pharmacol. 13, 324–330 (2013).
Bernstein, H.G. et al. Increased density of AKAP5-expressing neurons in the anterior cingulate cortex of subjects with bipolar disorder. J. Psychiatr. Res. 47, 699–705 (2013).
Ritschel, T. et al. Crystal structure analysis and in silico pKa calculations suggest strong pKa shifts of ligands as driving force for high-affinity binding to TGT. Chembiochem. 10, 716–727 (2009).
Shimizu, N. et al. The crystal structure of the R52Q mutant demonstrates a role for R52 in chromophore pKa regulation in photoactive yellow protein. Biochemistry 45, 3542–3547 (2006).
Kim, C., Xuong, N.H. & Taylor, S.S. Crystal structure of a complex between the catalytic and regulatory (RIalpha) subunits of PKA. Science 307, 690–696 (2005).
Solari, C.A. et al. Regulation of PKA activity by an autophosphorylation mechanism in Saccharomyces cerevisiae. Biochem. J. 462, 567–579 (2014).
Zhang, P. et al. Single Turnover Autophosphorylation Cycle of the PKA RIIbeta Holoenzyme. PLoS Biol. 13, e1002192 (2015).
Iyer, G.H., Moore, M.J. & Taylor, S.S. Consequences of lysine 72 mutation on the phosphorylation and activation state of cAMP-dependent kinase. J. Biol. Chem. 280, 8800–8807 (2005).
Byrne, A.M., Elliott, C., Hoffmann, R. & Baillie, G.S. The activity of cAMP-phosphodiesterase 4D7 (PDE 4D7) is regulated by protein kinase A-dependent phosphorylation within its unique N-terminus. FEBS Lett. 589, 750–755 (2015).
Paulucci-Holthauzen, A.A. & O’Connor, K.L. Use of pseudosubstrate affinity to measure active protein kinase A. Anal. Biochem. 355, 175–182 (2006).
Morgan, A.G. et al. Development and validation of a fluorescence technology for both primary and secondary screening of kinases that facilitates compound selectivity and site-specific inhibitor determination. Assay Drug. Dev. Technol. 2, 171–181 (2004).
Li, T., Liu, X., Liu, D. & Wang, Z. Sensitive detection of protein kinase A activity in cell lysates by peptide microarray-based assay. Anal. Chem. 85, 7033–7037 (2013).
Tang, S. et al. Cyclic-AMP-dependent protein kinase (PKA) activity assay based on FRET between cationic conjugated polymer and chromophore-labeled peptide. Analyst 139, 4710–4716 (2014).
Li, Y., Xie, W. & Fang, G. Fluorescence detection techniques for protein kinase assay. Anal. Bioanal. Chem. 390, 2049–2057 (2008).
Kasari, M. et al. Time-gated luminescence assay using nonmetal probes for determination of protein kinase activity-based disease markers. Anal. Biochem. 422, 79–88 (2012).
Xu, X. et al. Label-free fluorescent detection of protein kinase activity based on the aggregation behavior of unmodified quantum dots. Anal. Chem. 83, 52–59 (2011).
Allen, M.D. & Zhang, J. Subcellular dynamics of protein kinase A activity visualized by FRET-based reporters. Biochem. Biophys Res. Commun. 348, 716–721 (2006).
Chen, Y., Saulnier, J.L., Yellen, G. & Sabatini, B.L. A PKA activity sensor for quantitative analysis of endogenous GPCR signaling via 2-photon FRET-FLIM imaging. Front. Pharmacol. 5, 56 (2014).
Liu, S., Zhang, J. & Xiang, Y.K. FRET-based direct detection of dynamic protein kinase A activity on the sarcoplasmic reticulum in cardiomyocytes. Biochem. Biophys Res. Commun. 404, 581–586 (2011).
Lim, C.J. et al. Integrin-mediated protein kinase A activation at the leading edge of migrating cells. Mol. Biol. Cell 19, 4930–4941 (2008).
McKenzie, A.J., Campbell, S.L. & Howe, A.K. Protein kinase A activity and anchoring are required for ovarian cancer cell migration and invasion. PloS One 6, e26552 (2011).
Moskaug, J.O., Carlsen, H. & Blomhoff, R. Noninvasive in vivo imaging of protein kinase A activity. Mol. Imaging 7, 35–41 (2008).
Shults, M.D., Janes, K.A., Lauffenburger, D.A. & Imperiali, B. A multiplexed homogeneous fluorescencebased assay for protein kinase activity in cell lysates. Nat. Methods 2, 277–283 (2005).
Namkoong, S. et al. Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling. Cell. Signal. 21, 906–915 (2009).
Cho, Y.S. et al. Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression. Proc. Natl. Acad. Sci. USA 97, 835–840 (2000).
Pearce, L.R., Komander, D. & Alessi, D.R. The nuts and bolts of AGC protein kinases. Nat. Rev. Mol. Cell Biol. 11, 9–22 (2009).
Ubersax, J.A. & Ferrell, J.E., Jr. Mechanisms of specificity in protein phosphorylation. Nat. Rev. Mol. Cell Biol. 8, 530–541 (2007).
Jeon, H.Y. et al. C-reactive protein as a parameter for defining normal blood samples in identification and evaluation of serological biomarkers. Biochip J. 9, 35–43 (2015).
Kong, D.H. et al. Normalization using a tagged-internal standard assay for analysis of antibody arrays and the evaluation of serological biomarkers for liver disease. Anal. Chim. Acta 718, 92–98 (2012).
Jung, J.W. et al. Label-free and quantitative analysis of C-reactive protein in human sera by tagged-internal standard assay on antibody arrays. Biosens. Bioelectron. 24, 1469–1473 (2009).
Sambrook, J. & Russell, D.W. The condensed protocols from Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, N.Y., 2006; p v, 800 p.
Manning, G. et al. The protein kinase complement of the human genome. Science 298, 1912–1934 (2002).
Haubrich, B.A. & Swinney, D.C. Enzyme activity assays for protein kinases: Strategies to identify active substrates. Curr. Drug Discov. Technol. 13, 2–15 (2016).
Lochner, A. & Moolman, J.A. The many faces of H89: a review. Cardiovasc. Drug Rev. 24, 261–274 (2006).
Cvijic, M.E. et al. Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer. Clin. Cancer Res. 6, 2309–2317 (2000).
Wang, H. et al. Extracellular activity of cyclic AMPdependent protein kinase as a biomarker for human cancer detection: Distribution characteristics in a normal population and cancer patients. Cancer Epidem. Biomar. 16, 789–795 (2007).
Kita, T. et al. Extracellular cAMP-dependent protein kinase (ECPKA) in melanoma. Cancer Letters 208, 187–191 (2004).
Yi, S.J. et al. [Ca2+]-dependent generation of intracellular reactive oxygen species mediates maitotoxininduced cellular responses in human umbilical vein endothelial cells. Mol. Cell 21, 121–128 (2006).
Jung, J.W. et al. Label-free and quantitative analysis of C-reactive protein in human sera by tagged-internal standard assay on antibody arrays. Biosens. Bioelectron. 24, 1469–1473 (2009).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sayyed, D.R., Jung, SH., Kim, MS. et al. In situ PKA activity assay by selective detection of its catalytic subunit using antibody arrays. BioChip J 11, 57–66 (2017). https://doi.org/10.1007/s13206-016-1108-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13206-016-1108-5